CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-20 | McKenzie Libbie Parker Chief Medical Officer | Grant or award · Employee stock option (right to buy) | +696,793 | 696,793 | ||
| 2022-10-20 | Jain Deepak Chief Operating Officer | Grant or award · Employee stock option (right to buy) | +929,507 | 929,507 | ||
| 2022-10-20 | Girolamo Todd C Chief Legal Officer | Grant or award · Employee stock option (right to buy) | +696,793 | 696,793 | ||
| 2022-10-20 | Coulston James Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +325,170 | 325,170 | ||
| 2022-10-20 | Bertram Timothy Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +3,639,607 | 3,639,607 | ||
| 2022-09-20 | Fox Jennifer A. Director | Grant or award · Stock option (right to buy) | +129,370 | 129,370 | ||
| 2022-09-06 | Cowen Aaron 10% owner | Purchase | +7,007 | $6.99 | $49K | 6,280,175 |
| 2022-08-31 | Cowen Aaron 10% owner | Purchase | +1,062 | $8.93 | $9K | 6,271,068 |
| 2022-08-31 | Cowen Aaron 10% owner | Purchase | +2,100 | $8.94 | $19K | 6,273,168 |
| 2022-08-30 | Cowen Aaron 10% owner | Purchase | +706 | $7.49 | $5K | 6,270,006 |
| 2022-07-11 | Palihapitiya Chamath 10% owner | Grant or award | +9,500,000 | $10.00 | $95.0M | 10,140,000 |
| 2022-07-11 | Palihapitiya Chamath 10% owner | Grant or award | +3,000,000 | $10.00 | $30.0M | 13,140,000 |
| 2022-07-11 | Palihapitiya Chamath 10% owner | Option exercise | +6,220,000 | 19,360,000 | ||
| 2022-07-11 | Palihapitiya Chamath 10% owner | Other disposition | −3,087,000 | 16,273,000 | ||
| 2022-07-11 | Palihapitiya Chamath 10% owner | Option exercise · Class B ordinary shares | −6,220,000 | 0 | ||
| 2022-07-11 | Palihapitiya Chamath 10% owner | Grant or award | +9,000,000 | $10.00 | $90.0M | 9,640,000 |
| 2022-07-11 | Palihapitiya Chamath 10% owner | Option exercise | +6,220,000 | 15,860,000 | ||
| 2022-07-11 | Palihapitiya Chamath 10% owner | Other disposition | −3,087,000 | 12,773,000 | ||
| 2022-07-11 | Palihapitiya Chamath 10% owner | Option exercise · Class B ordinary shares | −6,220,000 | 0 | ||
| 2022-07-11 | SCS Sponsor III LLC Former Director and 10% Owner | Option exercise | +6,220,000 | 6,860,000 |
Page 10 of 12 · 231 trades